Skip to main content
FISCHER MEDICAL VENTURES LIMITED logo

FISCHER MEDICAL VENTURES LIMITED — Investor Relations & Filings

Ticker · FISCHER ISIN · INE771F01041 LEI · 6488FYP8HR283F177K40 BSE.NS Manufacturing
Open in API
Filings indexed 91 across all filing types
Latest filing 2026-05-25 Regulatory Filings
Country IN India
Listing BSE.NS FISCHER

About FISCHER MEDICAL VENTURES LIMITED

https://fischermv.com/

Fischer Medical Ventures Limited specializes in the development, manufacturing, and distribution of advanced medical diagnostic imaging equipment and healthcare technology solutions. The company focuses on providing high-end diagnostic systems, including Magnetic Resonance Imaging (MRI) scanners, Computed Tomography (CT) systems, and X-ray machines, aimed at improving clinical outcomes and diagnostic accuracy. Beyond manufacturing, the firm actively engages in strategic investments within the MedTech ecosystem, fostering innovation in digital health and medical devices. By leveraging cutting-edge technology and research, the company serves a broad spectrum of healthcare providers, ranging from large hospitals to specialized diagnostic centers, with a commitment to enhancing the accessibility and quality of medical imaging services through cost-effective and technologically superior products.

Recent filings

Filing Released Lang Actions
Fischer Medical Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve i) to consider and ....
Regulatory Filings
2026-05-25 English
Monitoring Agency Report
Capital/Financing Update Classification · 85% confidence The document is a Monitoring Agency Report filed under SEBI ICDR and LODR regulations relating to the utilisation of proceeds from a preferential equity share and warrant issue (a fundraising/capital structure matter). It is not an earnings release, annual report, or mere announcement—rather it provides substantive monitoring information on the company’s financing activity. Accordingly, it falls under Capital/Financing Update (CAP).
2026-05-15 English
Monitoring Agency Report for the quarter ended 31-03-2026
Regulatory Filings Classification · 90% confidence The document is a SEBI-mandated Monitoring Agency Report detailing the utilisation of funds raised through a preferential share issue for the quarter ended March 31, 2026. It is a compliance/regulatory filing under SEBI ICDR and LODR Regulations rather than an annual or quarterly financial report, earnings release, or governance presentation. There is no specific category for “Monitoring Agency Report,” so it falls under the general “Regulatory Filings” (RNS) category.
2026-05-15 English
Newspaper Advertisement- Special Window for Re-lodgement of Transfer requests for physical shares
Regulatory Filings Classification · 90% confidence The primary document is a compliance letter under SEBI (Listing Obligations and Disclosure Requirements) Regulation 30 informing stock exchanges that the Company has published a newspaper advertisement. This is a typical regulatory announcement (not a full report or financial statement) filed under exchange disclosure rules. Thus it falls under Regulatory Filings (RNS).
2026-05-15 English
Copy of Newspaper Publication
Regulatory Filings Classification · 82% confidence The document is framed as an exchange filing under SEBI Listing Regulations, providing a newspaper advertisement for a ‘Special Window for Re-lodgement of Transfer Requests’ (Regulation 30 disclosure) and includes multiple extract summaries of audited financial results published in newspapers per Regulation 33. It does not present a standalone annual or interim report nor a formal earnings release directly from a single issuer; rather it is a general regulatory announcement/compliance disclosure. Accordingly, it falls under the general “Regulatory Filings” category (RNS).
2026-05-15 English
Press Release
Regulatory Filings Classification · 83% confidence The document is a press release sent to the BSE and NSE announcing a landmark collaboration partnership. It contains no financial results, audit opinions, dividend details, board changes, or regulatory report attachments. It is a general corporate announcement for stock exchange dissemination and thus falls under the catch-all category for miscellaneous regulatory filings (RNS).
2026-05-14 English

Browse filings by year

2 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.